Liao Chuangxin, Chen Wenli, Wang Jinshan
Department of Neurosurgery, Eastern District of the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Department of Neurosurgery, Eastern District of the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
World Neurosurg. 2019 Jan;121:e519-e527. doi: 10.1016/j.wneu.2018.09.155. Epub 2018 Sep 28.
MicroRNAs (miRNAs) are a class of small noncoding RNAs that play important roles in tumor development and progression. miR-20a acts as an oncogene in many cancers; however, the underlying role of miR-20a in human glioma remains unknown.
Glioma tissue samples were obtained from 32 patients with primary glioma who had undergone surgery at the First Affiliated Hospital of Sun Yat-sen University (Guangzhou, China). Twenty-two normal brain tissue samples used as controls were obtained by internal decompression in patients who had undergone surgery for cerebral injury and cerebral hemorrhage at the same hospital.
Quantitative reverse transcription polymerase chain reaction showed upregulation of miR-20a in glioma tissues and cell lines compared with normal brain tissue and normal human astrocytes. Functional assays showed that miR-20a promotes proliferation and invasion and inhibits apoptosis in glioma cells. The bioinformatic analysis showed that CELF2 (CUGBP Elav-like family member 2) is a direct target gene of miR-20a, which was confirmed using a luciferase reporter assay. Downregulation of CELF2 reversed the effects of inhibiting miR-20a expression.
Collectively, these results suggest a critical role for miR-20a in glioma cell apoptosis, proliferation, and invasion via the direct targeting of CELF2 and indicate its potential application in cancer therapy.
微小RNA(miRNA)是一类小的非编码RNA,在肿瘤发生和发展中起重要作用。miR-20a在许多癌症中作为癌基因发挥作用;然而,miR-20a在人类胶质瘤中的潜在作用仍不清楚。
从中山大学附属第一医院(中国广州)接受手术的32例原发性胶质瘤患者中获取胶质瘤组织样本。作为对照的22例正常脑组织样本是从同一医院因脑损伤和脑出血接受手术的患者的内减压术中获得的。
定量逆转录聚合酶链反应显示,与正常脑组织和正常人星形胶质细胞相比,胶质瘤组织和细胞系中miR-20a上调。功能分析表明,miR-20a促进胶质瘤细胞的增殖和侵袭并抑制其凋亡。生物信息学分析显示,CELF2(CUGBP Elav样家族成员2)是miR-20a的直接靶基因,荧光素酶报告基因检测证实了这一点。CELF2的下调逆转了抑制miR-20a表达的作用。
总体而言,这些结果表明miR-20a通过直接靶向CELF2在胶质瘤细胞凋亡、增殖和侵袭中起关键作用,并表明其在癌症治疗中的潜在应用。